How UK Health Service Strikes Could Impact Patients

The NHS is a beloved institution, which has touched the lives of every UK citizen in one way, shape or form. Its current state leaves much to be desired, though, as a consequence of multiple different factors – from its chronic underfunding by the Conservative governments of the last ten years to the over-administration of staff by senior managers. The institution is being further tested by historic strike action over pay this year.

The NHS Pay Dispute

The NHS pay dispute broke into the news cycle at the start of 2023, with the formal announcement of a junior doctors’ strike. The main thrust of the strike was to achieve pay parity for junior doctors, in line with salaries at 2008-9. Over ten years, NHS staff have seen their pay cut in real terms, as wages have failed to rise with inflation.

The state of the economy makes this essential request difficult for the government to stomach, given the amount by which junior doctor pay has shrunk. In order to achieve parity, junior doctors would need to be paid over 25% more. Given the unwillingness of the government to budge, strike action has been taking place throughout the first half of the year.

Potential Patient Impacts

The strikes will unavoidably impact direct care and treatment for patients in the short term, where surgeries or consultations are re-arranged to account for staff absences. There could also be some further impacts felt by patients, where delays to appointments could lead to the misdiagnosis of dangerous conditions. Cancer misdiagnosis claims could result where patients aren’t receiving the care they need immediately, with potential long-term impacts on both health and personal lives.

The Reality

The operative word in the discussion of potential impacts for patients is ‘could’. While some impacts are unavoidable and indeed measurable, others are purely speculative. Meanwhile, the debate over patient safety in the short term minimises a key argument made by the striking NHS staff themselves, and a core component of the strike action: poorer patient safety and outcomes in the longer term.

A crucial point in the NHS dispute relates to the trend of underfunding that the institution has experienced over the past decade or so – starting with austerity measures introduced by David Cameron’s Conservative government and culminating in recent real-terms cuts to NHS pay. As funding dwindles for core services, patient outcomes worsen, and the institution loses vital existing and upcoming talent.

The short-term experience of delays to surgeries or other treatments is by no means analogous to the visceral damage caused – and yet to be caused – by failures in funding. Thankfully, there is some light at the end of the tunnel, with a deal struck between health unions and the Health Secretary relating to the pay of over a million NHS staff, including nurses and ambulance workers; a 5% pay rise and a one-off payment have been accepted by 14 unions.

 

 

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.